Mirum Pharmaceuticals (MIRM) Enterprise Value (2018 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Enterprise Value of -$386.3 million for Q1 2026, down 39.11% year-over-year from -$634.3 million in Q1 2025, and down 0.76% quarter-over-quarter from -$383.3 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Enterprise Value (2018 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Enterprise Value history runs 9 years deep, the most recent figure standing at -$386.3 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 39.11% year-over-year to -$386.3 million; the TTM figure through Mar 2026 stood at -$386.3 million (down 39.11% YoY), while the FY2025 annual figure was -$383.3 million, down 36.54% from the prior year.
- Enterprise Value for Q1 2026 stood at -$386.3 million, down from -$383.3 million in the prior quarter.
- The five-year high for Enterprise Value was -$94.0 million in Q3 2025, with the low at -$434.9 million in Q3 2022.
- The 5-year median for Enterprise Value is -$286.3 million (2023), against an average of -$280.5 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value tumbled 129.3% in 2024, then surged 66.95% in 2025.
- Mirum Pharmaceuticals' Enterprise Value stood at -$251.7 million in 2022, then fell by 13.75% to -$286.3 million in 2023, then grew by 1.95% to -$280.7 million in 2024, then tumbled by 36.54% to -$383.3 million in 2025, then decreased by 0.76% to -$386.3 million in 2026.
- Business Quant data shows MIRM's Enterprise Value at -$386.3 million in Q1 2026, -$383.3 million in Q4 2025, and -$94.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | -438.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -438.29 Mn |
| Mar 31, 2026 | -386.26 Mn |
| Dec 31, 2025 | -383.33 Mn |
| Sep 30, 2025 | -94.01 Mn |
| Jun 30, 2025 | -304.55 Mn |
| Mar 31, 2025 | -277.67 Mn |
| Dec 31, 2024 | -280.74 Mn |
| Sep 30, 2024 | -284.45 Mn |
| Jun 30, 2024 | -278.37 Mn |
| Mar 31, 2024 | -302.84 Mn |
| Dec 31, 2023 | -286.33 Mn |
| Sep 30, 2023 | -306.03 Mn |
| Jun 30, 2023 | -329.95 Mn |
| Mar 31, 2023 | -132.07 Mn |
| Dec 31, 2022 | -251.72 Mn |
| Sep 30, 2022 | -434.89 Mn |
| Jun 30, 2022 | -294.69 Mn |
| Mar 31, 2022 | -139.91 Mn |
| Dec 31, 2021 | -256.54 Mn |
| Sep 30, 2021 | -339.19 Mn |